Literature DB >> 1831586

Electrocardiographic diagnosis of left ventricular hypertrophy in the presence of bundle branch block.

B F Vandenberg1, D W Romhilt.   

Abstract

Autopsy and echocardiographic studies indicate that ECG criteria for LVH tend to maintain their sensitivity in the presence of LBBB, with the exception of left precordial lead criteria alone. With RBBB, ECG criteria for LVH using right precordial S waves and combination criteria of right precordial S waves and left precordial R waves have a marked reduction in sensitivity, whereas left precordial R wave criteria have modestly reduced sensitivity. Limb lead criteria for LVH have increased sensitivity in the presence of RBBB and, to a lesser extent, in the presence of LBBB. Acceptable sensitivity for the diagnosis of LVH in patients with bundle branch block requires a combination of limb and precordial lead voltage criteria and/or other nonvoltage ECG criteria, since the prevalence of LVH in the presence of RBBB or LBBB appears higher than the sensitivity of individual criteria.

Entities:  

Mesh:

Year:  1991        PMID: 1831586     DOI: 10.1016/0002-8703(91)90530-u

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Effect of right bundle branch block on electrocardiographic amplitudes, including combined voltage criteria used for the detection of left ventricular hypertrophy.

Authors:  Peter G Chan; Michael Logue; Paul Kligfield
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-07       Impact factor: 1.468

2.  Usefulness of ECG criteria to rule out left ventricular hypertrophy in older individuals with true left bundle branch block: an observational study.

Authors:  Caio Assis Moura Tavares; Nelson Samesima; Felippe Lazar Neto; Ludhmila Abrahão Hajjar; Lucas C Godoy; Eduardo Messias Hirano Padrão; Mirella Facin; Wilson Jacob Filho; Michael E Farkouh; Carlos Alberto Pastore
Journal:  BMC Cardiovasc Disord       Date:  2021-11-17       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.